Life-long Monitoring of Frail Patients With Chronic Diseases
NCT ID: NCT01608932
Last Updated: 2015-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
152 participants
INTERVENTIONAL
2012-04-30
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Monitoring to Prevent Frailty Progression in the Elderly
NCT05173870
Falls in Elderly and Telehealth: a Randomized Controlled Study
NCT02487589
Effect of Infections and Global DNA Methylation on Frailty Trajectories in Hospitalized Older Patients (INFRAGEN)
NCT06430073
Age-related Conditions in the Context of Multimorbidity and Frailty: Relative Weight of Frailty in Determining the Course and Outcomes of Different Chronic Diseases and Viceversa
NCT06324149
Epidemiological Observatory on the Health Conditions of Inpatients Aged 65 or Older at the INRCA Research Hospitals
NCT01397682
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
From a clinical point of view, the trial will investigate how the remote monitoring of some clinical parameters contributes to reduce the access to healthcare facilities (emergency and planned hospitalization, bed-days, ER, specialist and GP visits), to improve the patients health-related quality of life and to reduce the anxiety about health conditions. A cost-effectiveness and cost-utility analysis will be carried out in order to determine if and how telemonitoring helps to limit the healthcare expenditure. The evaluation will deal also with organizational changes and task shift due to telemonitoring introduction and patients and professionals perception towards the service.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Treatment as usual
No interventions assigned to this group
Telemonitoring for frail patients with chronic diseases
Telemonitoring for frail patients with chronic diseases
Telemonitoring for frail patients with chronic diseases
Patients are equipped with a telemonitoring kit that can be composed by a portable wrist clinic device, a digital weight scale and a glucometer for clinical parameters measuring, according to the pathologies of the patient. The equipment is completed by a gateway device for data transmission.
The patient can monitor a complete set of clinical parameters, such as pulse-oxymetry, heart rate, blood pressure, ECG, body weight and glycemia with a frequency set by the clinician in the personalized treatment plan. In the same protocol the clinician includes also the alarm thresholds that determine when the clinical measures are out-of-range. Data are transmitted to a regional eHealth centre where a group of operators keeps these information under control and alerts the general practitioner in case of worsening of symptoms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telemonitoring for frail patients with chronic diseases
Patients are equipped with a telemonitoring kit that can be composed by a portable wrist clinic device, a digital weight scale and a glucometer for clinical parameters measuring, according to the pathologies of the patient. The equipment is completed by a gateway device for data transmission.
The patient can monitor a complete set of clinical parameters, such as pulse-oxymetry, heart rate, blood pressure, ECG, body weight and glycemia with a frequency set by the clinician in the personalized treatment plan. In the same protocol the clinician includes also the alarm thresholds that determine when the clinical measures are out-of-range. Data are transmitted to a regional eHealth centre where a group of operators keeps these information under control and alerts the general practitioner in case of worsening of symptoms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of one or more of the following chronic diseases:
* Heart failure - diagnosis confirmed by echocardiogram or by a specialist assessment
* Type 1 or 2 diabetes - with HbA1C of 7.5 or greater in the previous 15 months
* Chronic Obstructive Pulmonary Disease (COPD) - diagnosis confirmed by spirometry and FEV1 ≤ 70% of predicted normal and/or FEV1/FVC ratio ≤ 70% or by a specialist assessment
* Have had a fall in the previous year or who are considered at high risk of falling
* Need home social care
* Have a caregiver who have difficulties to take care of him/her properly
* Cognitive impairment/confusion, but with caregiver able to use devices.
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Commission
OTHER
Local Health Authorities n. 4
UNKNOWN
Local Health Authorities n. 7
UNKNOWN
Local Health Authorities n. 9
UNKNOWN
Local Health Authorities n. 12
UNKNOWN
Local Health Authorities n. 13
UNKNOWN
Local Health Authorities n. 16
UNKNOWN
Local Health Authorities n. 20
UNKNOWN
SIMG (Italian College of General Medicine)
UNKNOWN
Regione Veneto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicolò Seminara, MD
Role: PRINCIPAL_INVESTIGATOR
SIMG - LHA 9 of Treviso
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Local Heath Authority of Padova
Padua, Padova, Italy
Local Health Authority of Pieve di Soligo
Pieve di Soligo, Treviso, Italy
Local Health Authority of Treviso
Treviso, Treviso, Italy
Local Health Authority of Mirano
Mirano, Venezia, Italy
Local Heath Authority Veneziana
Venezia, Venezia, Italy
Local Heath Authority of Verona
Verona, Verona, Italy
Local Heath Authority of Thiene
Thiene, Vicenza, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
G.A. 250487 - Veneto WP8Cl10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.